Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer

Published:2016-03-01 Issue:5 Volume:35 Page:2599-2605
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

REN BIQIONG,WEI XIAOBIN,ZOU GUOYING,HE JUNYU,XU GUOFENG,XU FEI,HUANG YIRAN,ZHU HAOWEN,LI YONG,MA GUOAN,YU PING

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer;Frontiers in Oncology;2022-04-27

2. Cancer/testis antigens: from serology to mRNA cancer vaccine;Seminars in Cancer Biology;2021-11

3. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer;Anti-Cancer Drugs;2021-09-22

4. Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma;Journal of Clinical Laboratory Analysis;2021-07-21

5. Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer;Current Oncology;2021-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP